|
1
|
Brodeur GM: Neuroblastoma: Biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brodeur GM and Fong CT: Molecular biology
and genetics of human neuroblastoma. Cancer Genet Cytogenet.
41:153–174. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Corvi R, Amler LC, Savelyeva L, Gehring M
and Schwab M: MYCN is retained in single copy at chromosome 2 band
23–24 during amplification in human neuroblastoma cells. Proc Natl
Acad Sci USA. 91:5523–5527. 1994. View Article : Google Scholar
|
|
5
|
Tsuda T, Obara M, Hirano H, Gotoh S,
Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N and
Shimizu K: Analysis of N-myc amplification in relation to disease
stage and histologic types in human neuroblastomas. Cancer.
60:820–826. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schulte JH, Horn S, Schlierf S, Schramm A,
Heukamp LC, Christiansen H, Buettner R, Berwanger B and Eggert A:
MicroRNAs in the pathogenesis of neuroblastoma. Cancer Lett.
274:10–15. 2009. View Article : Google Scholar
|
|
8
|
Das S, Bryan K, Buckley PG, Piskareva O,
Bray IM, Foley N, Ryan J, Lynch J, Creevey L, Fay J, et al:
Modulation of neuroblastoma disease pathogenesis by an extensive
network of epigenetically regulated microRNAs. Oncogene.
32:2927–2936. 2013. View Article : Google Scholar
|
|
9
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma miR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T
and Si J: Down-regulation of miR-141 in gastric cancer and its
involvement in cell growth. J Gastroenterol. 44:556–561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yaman Agaoglu F, Kovancilar M, Dizdar Y,
Darendeliler E, Holdenrieder S, Dalay N and Gezer U: Investigation
of miR-21, miR-141, and miR-221 in blood circulation of patients
with prostate cancer. Tumour Biol. 32:583–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y and Stallings RL: Differential
patterns of microRNA expression in neuroblastoma are correlated
with prognosis, differentiation, and apoptosis. Cancer Res.
67:976–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vance C, Rogelj B, Hortobágyi T, De Vos
KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P,
et al: Mutations in FUS, an RNA processing protein, cause familial
amyotrophic lateral sclerosis type 6. Science. 323:1208–1211. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwiatkowski TJ Jr, Bosco DA, Leclerc AL,
Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis
EJ, Munsat T, et al: Mutations in the FUS/TLS gene on chromosome 16
cause familial amyotrophic lateral sclerosis. Science.
323:1205–1208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brooke GN, Culley RL, Dart DA, Mann DJ,
Gaughan L, McCracken SR, Robson CN, Spencer-Dene B, Gamble SC,
Powell SM, et al: FUS/TLS is a novel mediator of androgen-dependent
cell-cycle progression and prostate cancer growth. Cancer Res.
71:914–924. 2011. View Article : Google Scholar
|
|
16
|
Khursheed K, Wilm TP, Cashman C, Quinn JP,
Bubb VJ and Moss DJ: Characterisation of multiple regulatory
domains spanning the major transcriptional start site of the FUS
gene, a candidate gene for motor neurone disease. Brain Res.
1595:1–9. 2015. View Article : Google Scholar
|
|
17
|
Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY,
Diccianni MB, London WB, Chang CH and Yu AL: microRNA signature and
expression of Dicer and Drosha can predict prognosis and delineate
risk groups in neuroblastoma. Cancer Res. 70:7841–7850. 2010.
View Article : Google Scholar : PubMed/NCBI
|
